News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

AAPAL Staff

Articles by AAPAL Staff

Resident/Fellow & Early Career Awards for Outstanding Essays on Psychiatric Leadership

December 13th 2023

Latest Updated Articles

Trending on Psychiatric Times

New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms

Loneliness, Meet Solitude

How to Approach Conversations With Adult Patients Who Might Have ADHD: New Tools and Insights

Accessory to War

FDA Approves Uzedy Once-Monthly Extended Release Injectable Suspension for Bipolar I Disorder

© 2025 MJH Life Sciences^®

All rights reserved.